Questions about how much you will pay? We are here to help.

A live specialist can help you understand your insurance coverage, monthly co-pay, and other support available to help you afford BIKTARVY®.

Call 1-800-226-2056 1-800-226-2056 or enroll online at www.GileadAdvancingAccess.com.

The amount a person pays for BIKTARVY depends on their individual circumstances and insurance plan. Below is a guide for what you can expect to pay.

Click on what best describes your coverage situation:


Typically a person taking BIKTARVY pays between $0 and $30 per month.

Eligible patients may pay as little as $0 per month with the Gilead Advancing Access® co-pay coupon. Terms and conditions apply.

The list price of BIKTARVY is $3,090 per month. The list price is not typically the price a patient pays.

Call 1-800-226-2056 1-800-226-2056 to talk to a specialist or enroll online at www.GileadAdvancingAccess.com.

Typically a person taking BIKTARVY pays between $0 and $5 per month.

If you are a part of the Extra Help Program, you can expect to pay between $4 and $9 per month.

If you are unsure whether you qualify for the Extra Help Program and would like more information, click here.

The list price of BIKTARVY is $3,090 per month. The list price is not typically the price a patient pays.

Typically a person taking BIKTARVY pays between $4 and $9 per month.

Some state Medicaid programs offer even lower co-pays, or eliminate co-pays altogether.

For more information about co-pays in your state, or whether you qualify for Medicaid, click here.

The list price of BIKTARVY is $3,090 per month. The list price is not typically the price a patient pays.

Support programs are available to help with insurance coverage and/or paying for prescription medicine.

Call the Advancing Access Patient Support Program at 1-800-226-2056 1-800-226-2056 to talk to a specialist who can help with a benefits investigation, or go to www.GileadAdvancingAccess.com and click on “Uninsured 24/7 Support” for immediate help. You may be able to receive the medication free of charge.

There are other federally funded programs that may be able to help. To learn more about the AIDS Drug Assistance Program (ADAP) in your state or territory, click here. To learn more about the Ryan White Program, click here, and to locate a Ryan White provider click here.

The list price of BIKTARVY is $3,090 per month. The list price is not typically the price a patient pays.

Call the Advancing Access Patient Support Program at 1-800-226-2056 1-800-226-2056 to talk to a specialist who can help you. The specialist can find programs to help you with insurance coverage and financial support to pay for BIKTARVY.

If you are uninsured, there is immediate help available. Visit www.GileadAdvancingAccess.com and click on the button that says “Uninsured 24/7 Support.”

The list price of BIKTARVY is $3,090 per month. The list price is not typically the price a patient pays.

Centers for Medicare & Medicaid Services. Announcement of calendar year (CY) 2019 Medicare Advantage capitation rates and Medicare Advantage and Part D payment policies and final call letter. https://www.cms.gov/MEDICARE/HEALTH-PLANS/MEDICAREADVTGSPECRATESTATS/DOWNLOADS/ANNOUNCEMENT2019.PDF. April 2, 2018.

Derived from data sourced from Symphony Health (Patient Transaction Data) (March 2018-February 2019, Accessed April 2019).

List price is also known as wholesale acquisition cost or WAC. WAC is listed as of April 19, 2019, for a 30-day supply of BIKTARVY.

US Department of Health and Human Services. Medicaid and CHIP overview for assisters. https://marketplace.cms.gov/technical-assistance-resources/fast-facts-medicaid-chip.pdf. Updated 2018. 

The information on this site is intended for audiences in the United States only. The content on this site may not apply to non-U.S. audiences as regulatory control, legal requirements and/or medical practices may vary in other countries.

BIKTARVY, the BIKTARVY Logo, EPCLUSA, the EPCLUSA Logo, GILEAD, the GILEAD Logo, ADVANCING ACCESS, SUPPORT PATH, and the SUPPORT PATH Logo are trademarks of Gilead Sciences, Inc., or its related companies. ASEGUA is a trademark of Asegua Therapeutics LLC. All other marks referenced herein are the property of their respective owners.

©2019 Gilead Sciences, Inc. All rights reserved. PTFC0458 10/19